MedPath

Naftin

NAFTIN NAFTIFINE HCl 1%

Approved
Approval ID

6371fceb-b98e-86a5-e053-2a91aa0a3d9e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 21, 2018

Manufacturers
FDA

Sebela Pharmaceuticals Inc.

DUNS: 079104574

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NAFTIFINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54766-770
Application NumberNDA019356
Product Classification
M
Marketing Category
C73594
G
Generic Name
NAFTIFINE HYDROCHLORIDE
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 21, 2018
FDA Product Classification

INGREDIENTS (7)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Inactive
Code: Z135WT9208
Classification: IACT
DIISOPROPANOLAMINEInactive
Code: 0W44HYL8T5
Classification: IACT
NAFTIFINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 g
Code: 25UR9N9041
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Naftin - FDA Drug Approval Details